510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K091616Substantially Equivalent

Bioplex 2200 Mmrv Igg

Bio-Rad Laboratories Inc., Redmond WA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K091616 is the FDA 510(k) clearance record for BIOPLEX 2200 MMRV IGG, a class II device, cleared for Bio-Rad Laboratories on under FDA product code OPL (Multiplex Immunoassay For Measles Virus, Mumps Virus, Rubella And Varicella Zoster Virus). FDA's definition for product code OPL reads: "The test is a multiplex immunoassay intended for the qualitative detection of specific human IgG antibodies to measles virus, mumps virus, Rubella and varicella zoster virus (VZV) in human serum and/ or plasma. The results of this assay...". FDA records list 128 510(k) clearances for Bio-Rad Laboratories, from to . As of , FDA records show no recalls naming K091616.

Clearance record

Decision date
Received
(299 days to decision)
Product code
OPL Multiplex Immunoassay For Measles Virus, Mumps Virus, Rubella And Varicella Zoster Virus
Regulation
21 CFR 866.3510
Device class
Class II
Review panel
Microbiology
Applicant
Bio-Rad Laboratories 6565 185th Ave., NE, Redmond WA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code OPL

Trailing 12 months

FDA records hold no clearances under product code OPL in the trailing twelve months.

FDA records show no clearances under product code OPL in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code OPL, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260